Ikarian Capital, LLC Portfolio Holdings

Ikarian Capital, LLC

  • $606 Million
  • Q4 2024

Ikarian Capital, LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $606 Million distributed in 171 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Tarsus Pharmaceuticals, Inc. with a value of $33.6M, Crinetics Pharmaceuticals, Inc. with a value of $26.4M, Scholar Rock Holding Corp with a value of $15.4M, Blueprint Medicines Corp with a value of $14.8M, and Viridian Therapeutics, Inc.\De with a value of $9.01M.

Examining the 13F form we can see an increase of $33.4M in the current position value, from $573M to 606M.

Ikarian Capital, LLC is based out at Dallas, TX

Below you can find more details about Ikarian Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $606 Million
Healthcare: $418 Million
ETFs: $131 Million
Consumer Defensive: $57.5 Million

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$63.9M
$840,000 0.14% of portfolio
500,000
Q4 2024 New
$466M
$834,000 0.14% of portfolio
60,000
Q4 2024 New
$176M
$758,000 0.13% of portfolio
201,187
Q4 2024 Reduced 26.72%
$173M
$816,000 0.13% of portfolio
1,276,037
Q4 2024 Added 142.56%
$109M
$719,000 0.12% of portfolio
175,088
Q4 2024 Reduced 0.01%
$673M
$659,000 0.11% of portfolio
34,985
Q4 2024 Reduced 86.54%
$41.7M
$614,000 0.1% of portfolio
945,239
Q4 2024 Reduced 0.12%
$258M
$603,000 0.1% of portfolio
78,585
Q4 2024 Added 0.01%
$485M
$594,000 0.1% of portfolio
365,000
Q4 2024 New
$172M
$536,000 0.09% of portfolio
91,994
Q4 2024 Reduced 0.01%
$49.8M
$457,000 0.08% of portfolio
265,769
Q4 2024 Reduced 0.25%
$16.6M
$430,000 0.07% of portfolio
213,052
Q4 2024 Reduced 0.16%
$11M
$400,000 0.07% of portfolio
690,050
Q4 2024 Reduced 0.01%
$8.25M
$410,000 0.07% of portfolio
1,000,000
Q4 2024 New
$1.25B
$393,000 0.06% of portfolio
22,600
Q4 2024 New
$488M
$278,000 0.05% of portfolio
408,899
Q4 2024 Reduced 0.11%
$13.8M
$324,000 0.05% of portfolio
649,963
Q4 2024 Reduced 0.01%
$28.5M
$264,000 0.04% of portfolio
157,720
Q4 2024 Reduced 0.09%
$406M
$221,000 0.04% of portfolio
83,407
Q4 2024 Added 0.15%
$146M
$260,000 0.04% of portfolio
80,071
Q4 2024 Reduced 0.01%
$5.73M
$222,000 0.04% of portfolio
1,058,148
Q4 2024 Added 0.12%
$118M
$223,000 0.04% of portfolio
58,526
Q4 2024 Reduced -0.0%
$2.86B
$114,000 0.02% of portfolio
3,594
Q4 2024 New
$322M
$74,000 0.01% of portfolio
6,798
Q4 2024 Reduced 0.26%
$8.13M
$88,000 0.01% of portfolio
105,285
Q4 2024 Reduced 0.3%
$216M
$12,000 0.0% of portfolio
1,400
Q4 2024 New
$135M
$0 0.0% of portfolio
40
Q4 2024 Added 2.56%
$92.1M
$0 0.0% of portfolio
100
Q4 2024 New
$7.44M
$20,000 0.0% of portfolio
40,270
Q4 2024 Reduced 0.25%
$3.55B
$16,000 0.0% of portfolio
600
Q4 2024 New
$40.9M
$9,000 0.0% of portfolio
8,924
Q2 2024 New
$13.1M
$1,000 0.0% of portfolio
6,501
Q4 2024 New

Summary

  • Portfolio
  • No. of Stocks 171
  • Current Value $606 Million
  • Prior Value $573 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 44 stocks
  • Additional Purchases 21 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 56 stocks
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email